150 related articles for article (PubMed ID: 8476217)
1. Growth inhibitory substances in human breast cyst fluid.
Lai LC; Chan CT; Cornell C; Lennard TW
Anticancer Res; 1993; 13(1):225-7. PubMed ID: 8476217
[TBL] [Abstract][Full Text] [Related]
2. Oestradiol and epidermal growth factor in breast cyst fluid.
Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.
Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S
Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid.
Lai LC; Siraj AK; Erbas H; Lennard TW
Anticancer Res; 1994; 14(6B):2805-9. PubMed ID: 7872722
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M, interleukin 2, interleukin 6 and interleukin 8 in breast cyst fluid.
Lai LC; Kadory S; Siraj AK; Lennard TW
Int J Cancer; 1994 Nov; 59(3):369-72. PubMed ID: 7927943
[TBL] [Abstract][Full Text] [Related]
7. Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast.
Naldoni C; Costantini M; Dogliotti L; Bruzzi P; Bucchi L; Buzzi G; Torta M; Angeli A
Cancer Res; 1992 Apr; 52(7):1791-5. PubMed ID: 1551110
[TBL] [Abstract][Full Text] [Related]
8. Relationships between oestrogen-inducible proteins, oestradiol and electrolyte ratio in breast cyst fluid.
Lai LC; Cornell C; Lennard TW
Cancer Lett; 1993 Apr; 69(1):21-5. PubMed ID: 8481890
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor and oestradiol in human breast cyst fluid.
Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; Shaikh NA; James VH
Eur J Cancer; 1990 Apr; 26(4):481-4. PubMed ID: 2141515
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of breast cyst fluid as a possible predictor of breast carcinoma development.
Simíøcková M; Pecen L; Eben K; Nekulová M; Vermousek I; Stratil P; Rejthar A; Cernoch M; Lang B; Sakalová J
Neoplasma; 1994; 41(5):245-52. PubMed ID: 7854493
[TBL] [Abstract][Full Text] [Related]
11. Presence of epidermal growth factor receptor in breast smears of cyst fluids: relationship to electrolyte ratios and pH concentration.
Athanassiadou PP; Veneti SZ; Kyrkou KA; Intzes KS; Mouzaka LI; Papadimitriou GK
Cancer Detect Prev; 1992; 16(2):113-8. PubMed ID: 1600520
[TBL] [Abstract][Full Text] [Related]
12. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content.
Zanardi S; Pensa F; Torrisi R; De Franchis V; Barreca A; Minuto F; Boccardo F
Int J Cancer; 1994 Dec; 59(6):725-7. PubMed ID: 7989108
[TBL] [Abstract][Full Text] [Related]
13. Latent forms of transforming growth factor-beta 2 (TGF-beta 2) in breast cyst fluid.
Erbas H; Lennard TW; Lai LC
Anticancer Res; 1999; 19(4B):3077-82. PubMed ID: 10652596
[TBL] [Abstract][Full Text] [Related]
14. Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk.
Budai B; Számel I; Sulyok Z; Németh M; Bak M; Kralovánszky J; Ottó S; Besznyák I; Purohit A; Parish DC; Reed MJ
Anticancer Res; 2000; 20(5C):3879-86. PubMed ID: 11268470
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios.
Lai LC; Ghatei MA; Takahashi K; Patel KV; Schrey MP; Ghilchik MW; Bloom SR; James VH
Int J Cancer; 1990 Dec; 46(6):1014-6. PubMed ID: 2249889
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.
Alexandrakis MG; Coulocheri SA; Bouros D; Eliopoulos GD
Anticancer Res; 1999; 19(4C):3607-12. PubMed ID: 10629659
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.
Torrisi R; Zanardi S; Pensa F; Valenti G; De Franchis V; Nicolo G; Barreca A; Minuto F; Boccardo F
Breast Cancer Res Treat; 1995 Mar; 33(3):219-24. PubMed ID: 7749149
[TBL] [Abstract][Full Text] [Related]
18. [Epidermal growth factor behavior in breast cyst fluid. Differences as a function of the three existing types].
Vizoso F; Fueyo A; Díez MC; Ruibal A
Rev Clin Esp; 1991 Sep; 189(4):194-5. PubMed ID: 1745812
[No Abstract] [Full Text] [Related]
19. Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified?
Miller WR; Scott WN; Harris WH; Wang D
Cancer Detect Prev; 1992; 16(2):99-106. PubMed ID: 1600527
[TBL] [Abstract][Full Text] [Related]
20. Electrolytes and trace elements in human breast cyst fluid.
Sişman AR; Sis B; Canda T; Onvural B
Biol Trace Elem Res; 2009 Apr; 128(1):18-30. PubMed ID: 18972071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
